Refine results:

Clear all

Three potential coronavirus vaccines in a tray

Opinion | 27 March 2020

A new way of developing vaccines for COVID-19 could help the world to prepare for future outbreaks by Charlie Weller

A vaccine for COVID-19 which uses cutting-edge RNA technology has entered phase 1 clinical trials. If successful, it could revolutionise the future of vaccine development.

Woman wears face mask and pushes shopping trolley

Opinion | 27 February 2020

Global institutions must act urgently and decisively to tackle COVID-19 by Jeremy Farrar

The COVID-19 outbreak is not just a public health crisis, it’s rapidly becoming a global crisis – of health, economics and politics.

A researcher expresses coronavirus, Covid-19, onto surface protein, in a research lab

Opinion | 19 February 2020

COVID-19: how researchers around the world are racing to understand the virus and prevent future outbreaks by Josie Golding

As the outbreak of COVID-19 continues to spread in China and countries around the world, a global community of researchers are working to find out more about the virus and assess what research needs to be done to stop it.

People wearing surgical masks sitting in subway in Shanghai, China.

News | 13 February 2020

Wellcome pledges £10 million to tackle COVID-19 epidemic

Wellcome is making a pledge of up to £10 million to accelerate research and support global efforts to tackle the ongoing coronavirus (COVID-19) epidemic.

Illustration of a spoon with pills

Q&A | 21 January 2020

Why is it so hard to develop new antibiotics?

Discovering and then bringing new antibiotics to market is a tricky challenge – but one we need to solve if we want to be better protected against the growing threat of drug-resistant infections. Here’s why, and what has to happen to develop new medicines.

People sat at a table get vaccinated against Ebola as part of a community event.

Opinion | 18 December 2019

This is the decade we made one of the world’s deadliest diseases preventable and curable by Jeremy Farrar

The commitment to research during the last two Ebola outbreaks has changed the course of this disease. Jeremy Farrar reflects on what made this possible.

Liz Corbett and a colleague in the lab. Liz is head of the HIV/TB research group at the Malawi-Liverpool-Wellcome Trust Clinical Research Programme.

News | 17 December 2019

Stellar science and research funded by another year of strong investment returns

Strong investment returns in 2019 meant Wellcome was able to spend over £1.1 billion on improving health for everyone.

A five week old boy gets the Ebola vaccine.

Opinion | 14 November 2019

Landmark moment in the fight against Ebola: what have we learnt? by Charlie Weller

The licensing of the first Ebola vaccine is a great achievement for the global healthcare community. What made it possible, and what lessons can we use to prevent and control future outbreaks?

A baby in hospital with measles in the Philippines

Opinion | 10 September 2019

Why are we seeing spikes in measles compared to other infectious diseases? by Charlie Weller

It seems that we hear a lot about measles compared to other infectious diseases, such as rubella or whooping cough. But why?

Face to face interview taking place in Benin as part of the Gallup World Poll 2018..

Opinion | 13 August 2019

The most important healthcare tool is trust by Jeremy Farrar

Wellcome Global Monitor shows that 70% of people trust scientists, doctors, and nurses.

Young girl watches Ebola response team prepare vaccination equipment.

Opinion | 2 August 2019

How research has fundamentally changed the response to Ebola in DRC by Josie Golding

It's a year since the Ebola outbreak in the Democratic Republic of the Congo began. If we want to prevent future outbreaks lasting a year, the world needs to address research gaps.

Pages